Through increased collaboration between Cornell Health and Weill Cornell Medicine, this spring two new partnerships – with another on the way – will enhance and expand services to the Ithaca campus community to better meet the needs of Cornell students.
Ocular drift, a very subtle and seemingly random type of eye movement, can be influenced by prior knowledge of the expected visual target, suggesting a surprising level of cognitive control over the eyes, according to a study led by Weill Cornell Medicine neuroscientists.
New research suggests a strategy to ward off age-related weight gain, which could prevent obesity and associated health disorders like Type 2 diabetes, heart disease and chronic inflammation.
Hospitals have begun using “decision support tools” powered by artificial intelligence that can diagnose disease, suggest treatment or predict a surgery’s outcome.
White blood cells called neutrophils have an unappreciated role in eradicating solid tumors, according to a surprise discovery from a team led by Weill Cornell Medicine scientists.
A Cornell research scientist used ground-penetrating radar and AI modeling to locate the communal graves of approximately 93 victims of the Spanish influenza at Pilgrim Hot Springs in Alaska.
A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity, according to a new study led by a team of researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Ekta Khurana, associate professor of physiology and biophysics at Weill Cornell Medicine, has received a three-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy.
